✦ LIBER ✦

Activity of azacitidine in chronic myelomonocytic leukemia

✍ Scribed by Rubens Costa; Haifaa Abdulhaq; Bushra Haq; Richard K. Shadduck; Joan Latsko; Mazen Zenati; Folefac D. Atem; James M. Rossetti; Entezam A. Sahovic; John Lister

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 261 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25759

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of decitabine, a hypomethylatin

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia

✍ Ahmed Aribi; Gautam Borthakur; Farhad Ravandi; Jianqin Shan; Jan Davisson; Jorge 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract ## BACKGROUND. Hypomethylating agents have activity in myelodysplastic syndrome (MDS) and have received approval for the treatment of both MDS and chronic myelomonocytic leukemia (CMML). The specific efficacy in CMML has not been detailed in a large number of patients. The aim of the s

Disseminated coagulopathy in chronic mye

Disseminated coagulopathy in chronic myelomonocytic leukemia

✍ Roger D. Gingrich; C. Patrick Burns 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Chronic myelomonocytic leukemia: lost in

Chronic myelomonocytic leukemia: lost in classification?

✍ David T Bowen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Chronic myelomonocytic leukemia (CMML) comprises a spectrum of disease variably considered as a myelodysplastic (MDS) and/or myeloproliferative (MPD) disorder. Now classified by the WHO within a separate nosological group from MDS or MPD, the reality is that there is a dynamic of evolution through i

Meningeal involvement of chronic myelomo

Meningeal involvement of chronic myelomonocytic leukemia

✍ Koji Aoyama; H. Ishikura; H. Tsumura; T. Watanabe; N. Suyama; S. Kumakura; S. Ko 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 169 KB

Diagnosis and management of chronic myel

Diagnosis and management of chronic myelomonocytic leukemia

✍ Francesco Onida; Miloslav Beran 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 157 KB

Lymphoblastic transformation of chronic

Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant

✍ Yamamoto, Masuji; Nakagawa, Makiko; Ichimura, Noriko; Ohtsuki, Fumiko; Ohtsuka, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

A 10-month-old infant with chronic myelomonocytic leukemia (CMML) of 5 months' duration, who had been treated only with transfusion, displayed leukemic transformation characterized by lymphoid morphology, PAS positivity, and myeloperoxidase negativity. Surface marker analysis of blast cells revealed